Ultra-high dose rate (FLASH) radiotherapy: Silver bullet or fool's gold?
JD Wilson, EM Hammond, GS Higgins… - Frontiers in …, 2020 - frontiersin.org
Radiotherapy is a cornerstone of both curative and palliative cancer care. However,
radiotherapy is severely limited by radiation-induced toxicities. If these toxicities could be …
radiotherapy is severely limited by radiation-induced toxicities. If these toxicities could be …
Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review
N Esplen, MS Mendonca… - Physics in Medicine & …, 2020 - iopscience.iop.org
Ultrahigh dose-rate radiotherapy (RT), or'FLASH'therapy, has gained significant momentum
following various in vivo studies published since 2014 which have demonstrated a reduction …
following various in vivo studies published since 2014 which have demonstrated a reduction …
Ultra‐high dose rate electron beams and the FLASH effect: from preclinical evidence to a new radiotherapy paradigm
In their seminal paper from 2014, Fauvadon et al. coined the term FLASH irradiation to
describe ultra‐high‐dose rate irradiation with dose rates greater than 40 Gy/s, which results …
describe ultra‐high‐dose rate irradiation with dose rates greater than 40 Gy/s, which results …
The challenge of ionisation chamber dosimetry in ultra-short pulsed high dose-rate Very High Energy Electron beams
M McManus, F Romano, ND Lee, W Farabolini… - Scientific reports, 2020 - nature.com
High dose-rate radiotherapy, known as FLASH, has been shown to increase the differential
response between healthy and tumour tissue. Moreover, Very High Energy Electrons …
response between healthy and tumour tissue. Moreover, Very High Energy Electrons …
PHASER: A platform for clinical translation of FLASH cancer radiotherapy
PG Maxim, SG Tantawi, BW Loo Jr - Radiotherapy and Oncology, 2019 - Elsevier
Pluridirectional high-energy agile scanning electronic radiotherapy (PHASER) is next-
generation medical linac technology for ultra-rapid highly conformal image-guided radiation …
generation medical linac technology for ultra-rapid highly conformal image-guided radiation …
FLASH: New intersection of physics, chemistry, biology, and cancer medicine
Ultrahigh dose rate, FLASH radiotherapy has emerged as one of the most promising
innovations over the past decade in the field of radiation oncology, with the potential to …
innovations over the past decade in the field of radiation oncology, with the potential to …
Perspectives on the generation of electron beams from plasma-based accelerators and their near and long term applications
This article first gives the authors' perspectives on how the field of plasma-based
acceleration (PBA) developed and how the current experiments, theory, and simulations are …
acceleration (PBA) developed and how the current experiments, theory, and simulations are …
An experimental study of focused very high energy electron beams for radiotherapy
K Kokurewicz, E Brunetti, A Curcio, D Gamba… - Communications …, 2021 - nature.com
Very high energy electron (VHEE) beams have been proposed as an alternative
radiotherapy modality to megavoltage photons; they penetrate deeply without significant …
radiotherapy modality to megavoltage photons; they penetrate deeply without significant …
Radiotherapy and systemic therapies: focus on head and neck Cancer
F De Felice, CG Cattaneo, P Franco - Cancers, 2023 - mdpi.com
Simple Summary This review provides some highlights in the current radio (chemo) therapy
strategy for head and neck squamous cell carcinoma (HNSCC). The aim is to lead to a better …
strategy for head and neck squamous cell carcinoma (HNSCC). The aim is to lead to a better …
[HTML][HTML] FLASH radiotherapy treatment planning and models for electron beams
M Rahman, A Trigilio, G Franciosini, R Moeckli… - Radiotherapy and …, 2022 - Elsevier
The FLASH effect designates normal tissue sparing at ultra-high dose rate (UHDR,> 40
Gy/s) compared to conventional dose rate (∼ 0.1 Gy/s) irradiation while maintaining tumour …
Gy/s) compared to conventional dose rate (∼ 0.1 Gy/s) irradiation while maintaining tumour …